Tech Company Financing Transactions
CND Life Sciences Funding Round
Top Corner Capital invested in a $4.5 million Seed funding round for CND Life Sciences. The funding round was announced on 4/6/2023.
Transaction Overview
Company Name
Announced On
4/6/2023
Transaction Type
Venture Equity
Amount
$4,500,000
Round
Seed
Investors
Top Corner Capital (Lead Investor)
Proceeds Purpose
The company intends to use the funds to accelerate the commercialization of Syn-One with nearly 700 neurologist clinician customers in over 40 states and collaborations with biopharmaceutical companies.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
9165 E Del Camino Dr,
Scottsdale, AZ 85258
USA
Scottsdale, AZ 85258
USA
Phone
Website
Email Address
Overview
Since our founding, CND Life Sciences has been on a mission to advance the care of patients who face the potential diagnosis of a neurodegenerative disease. With long careers in research and clinical care, our founders? set out to unlock? deeper stories within the skin by? detecting key pathological markers in the peripheral nervous system that had been previously out of reach.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Richard Morello
Chief Medical Officer
Todd Levine
Browse more venture capital transactions:
Prev: 4/6/2023: Tally Health venture capital transaction
Next: 4/6/2023: Calida Therapeutics venture capital transaction
Share this article
News on VC Transactions
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs